C-MET activation is a common event in numerous cancers, driving a number of proliferation, differentiation, and survival signaling pathways, including sustained Ras/MAPK activity, as well as PI3K, STAT, β-catenin, NFκB, and Notch activation [137] (Figure 3). This evidence concerns the gene MET and cancer.